Stocks:
5,168
ETFs:
2,288
Exchanges:
11
Market Cap:
$65.69T
24h Vol:
$10.68B
Dominance:
MSFT:4.75%
Stocklytics Platform
Asset logo  CLVT
Clarivate Plc
CLVT
68 / 100
$6.01arrow_drop_down2.75%-$0.17

Performance History

Stocklytics logo
Key Stats
Open$6.19
Prev. Close$6.18
EPS-1.65
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$4.01B
PE Ratio-
LOWHIGH
Day Range6.00
6.20
52 Week Range6.00
10.03
Ratios
P/B Ratio1.03
Revenue$2.62B
Operating M. %5.62%
Earnings$0.00
Earnings Growth %76.99%
EBITDA Margin %37.58%
ROE %-16.03%
EPS-1.65

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

info
Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Correlated Companies

PRICE$420.20
24H (%)arrow_drop_down0.18%
24H ($)-$0.78
MARKET CAP$3.12T
PRICE$189.87
24H (%)arrow_drop_up0.01%
24H ($)$0.03
MARKET CAP$2.90T
PRICE$924.78
24H (%)arrow_drop_down1.99%
24H ($)-$18.80
MARKET CAP$2.27T
PRICE$1,395.29
24H (%)arrow_drop_down1.19%
24H ($)-$16.83
MARKET CAP$645.82B

About Clarivate Plc (CLVT)

Clarivate Plc, an information, analytics, and workflow company, provides structured information and analytics for discovery, development, protection, commercialization, and measurement of scientific research, innovations, and brands. The company operates through three segments: Academia and Government, Life Sciences and Healthcare, and Intellectual Property. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ProQuest One, Pivot, Polaris, eBook Central, Vegs, Alma, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis products for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs; and Real World Data, Dialog, Drug Safety Triager, and healthcare and data solutions. The company also provides Derwent products, which include Derwent Innovation, Innography, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; and CompuMark products, such as trademark screening, searching, and watching products and services. It serves government and academic institutions, and life science and healthcare companies in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.

Sector
Technology
Industry
Information Technology Services
CEO
Mr. Jonathan Gear
Headquarters
London
Employees
11600
Exchange
NYSE
add Clarivate Plc to watchlist

Keep an eye on Clarivate Plc

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is Clarivate Plc's (CLVT) price per share?

The current price per share for Clarivate Plc (CLVT) is $6.01. The stock has seen a price change of -$0.17 recently, indicating a -2.75% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for Clarivate Plc (CLVT)?

For Clarivate Plc (CLVT), the 52-week high is $10.03, which is 66.89% from the current price. The 52-week low is $6, the current price is 0.17% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is Clarivate Plc (CLVT) a growth stock?

Clarivate Plc (CLVT) has shown an average price growth of 0.41% over the past three years. It has received a score of 15 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Clarivate Plc as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is Clarivate Plc (CLVT) stock price performance year to date (YTD)?

As of the latest data, Clarivate Plc (CLVT) has a year-to-date price change of -33.81%. Over the past month, the stock has experienced a price change of -13.02%. Over the last three months, the change has been -32.7%. Over the past six months, the figure is -16.64%.

help
Is Clarivate Plc (CLVT) a profitable company?

Clarivate Plc (CLVT) has a net income of -$911.2M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 38.58% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 5.62% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $2.63B, although specific revenue growth data is currently not available. The gross profit is $1.01B. Operating income is noted at $274.4M. Furthermore, the EBITDA is $985.1M.

help
What is the market capitalization of Clarivate Plc (CLVT)?

Clarivate Plc (CLVT) has a market capitalization of $4.02B. The average daily trading volume is 5.22M, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level